Research Use Only
CJC-1295 no DAC + Ipamorelin
CAS #863288-34-0
$78.00
CJC-1295 No DAC (Drug Affinity Complex)
- CAS #
- 863288-34-0
- Suggested Association
- Muscle growth, fat metabolism
- Indicated Involvement
- Periodic release of growth hormone
Not currently approved for therapeutic use by the FDA
Ipamorelin
- CAS #
- 170851-70-4
- Suggested Association
- Growth hormone modulation
- Indicated Involvement
- Release of growth hormone
Not currently approved for therapeutic use by the FDA
References
- National Institutes of Health (NIH). Research on peptide therapeutics.
- FDA. Drug Approvals and Databases.
- CJC-1295 No DAC Overview. (2018). In Journal of Peptide Research.
- Ipamorelin Research. (2020). In Clinical Endocrinology.